ICON Plc

ICON Plc ICON is a global provider of outsourced clinical research development services to the pharmaceutical, biotechnology, and medical device industries.

We help our clients accelerate the development of life-saving drugs that improve patients' quality of life.

ICON is once again sponsoring and presenting at on 6–7 May in Barcelona, which focuses on the evolving needs of the bi...
13/04/2026

ICON is once again sponsoring and presenting at on 6–7 May in Barcelona, which focuses on the evolving needs of the biotechnology sector within clinical research. The meeting highlights scientific innovation alongside practical approaches to clinical ex*****on and development planning.

Visit booth #52 to engage with the ICON team and learn how our biotech-focused solutions help sponsors navigate clinical development throughout the entire drug development lifecycle. https://ow.ly/2CL550YBCjj

Frequentist and Bayesian frameworks in NMADifferent analytical paradigms offer different strengths. The whitepaper sets ...
13/04/2026

Frequentist and Bayesian frameworks in NMA

Different analytical paradigms offer different strengths. The whitepaper sets out the contrasting roles of frequentist regression based models and Bayesian hierarchical models, including how each supports treatment ranking and interpretation.

It also describes why Bayesian outputs are particularly useful for probabilistic sensitivity analyses within economic modelling.

Learn more: https://ow.ly/TTzc50YwbaZ

Selecting the right pediatric HRQoL instrument is no longer optional. It’s a regulatory expectation. Our latest blog bre...
10/04/2026

Selecting the right pediatric HRQoL instrument is no longer optional. It’s a regulatory expectation. Our latest blog breaks down a six criterion framework to guide sponsors in making defensible, patient focused choices, and puts the PedsQL™ to the test. Read how this framework helps sponsors avoid late stage regulatory uncertainty and strengthen pediatric endpoint strategy. https://ow.ly/IB5850YBKhl

In many neurodegenerative diseases, changes in the brain begin years before clinical signs emerge. New technologies and ...
10/04/2026

In many neurodegenerative diseases, changes in the brain begin years before clinical signs emerge. New technologies and methods are enabling earlier diagnosis and intervention. Explore how pragmatic adoption of these innovations can accelerate and de-risk your neurodegenerative clinical trials. Download the whitepaper: https://ow.ly/eG6w50Yv7EA

Although long-term follow-up for vaccines may seem distant during early planning, determining the best approach as soon ...
10/04/2026

Although long-term follow-up for vaccines may seem distant during early planning, determining the best approach as soon as possible ensures the greatest benefit from follow-up efforts. Read the article to explore key questions developers should ask to guide the choice between traditional onsite follow-up and tokenisation. https://ow.ly/QNZG50YEsGO

A little healthy competition goes a long way.At our ICON Chennai Office, teams recently came together for the ICON Emplo...
10/04/2026

A little healthy competition goes a long way.

At our ICON Chennai Office, teams recently came together for the ICON Employee Recreation Club(IERC) Badminton League 2026, with more than 300 colleagues taking part or cheering from the sidelines.

From fast paced doubles matches to some seriously competitive finals, the day was full of energy, great rallies, and plenty of support from the crowd. More importantly, it was a chance for people across teams to connect, have fun, and step away from the day to day.

Events like this are a reminder that strong teams are built on more than just the work we do. They are built on shared moments, connections, and a bit of friendly rivalry.

Marking 25 years at ICON, Ricardo Cortizo Justo reflects a career built on progression, consistency, and delivering qual...
09/04/2026

Marking 25 years at ICON, Ricardo Cortizo Justo reflects a career built on progression, consistency, and delivering quality in clinical operations.

In this Q&A, Ricardo reflects on his journey from CRA to leadership, the importance of adaptability, and how clinical trials have evolved over time.

A valuable perspective for anyone building a career in clinical research.

Explore the full story: https://ow.ly/xZKM50YFAox

As part of the PharmaSUG India Single Day Event on 11 April at the Eli Lilly office in Bangalore, Dimpy Modak, Director ...
09/04/2026

As part of the PharmaSUG India Single Day Event on 11 April at the Eli Lilly office in Bangalore, Dimpy Modak, Director of Biometrics, will deliver a presentation titled “The future of statistical programming in the age of AI.”

Her session will focus on the evolving role of AI and ML in modern statistical workflows. https://ow.ly/H15H50YEs5V

High quality real world evidence and transparent analytical methods remain central to how managed care evaluates clinica...
08/04/2026

High quality real world evidence and transparent analytical methods remain central to how managed care evaluates clinical and economic value. At , ICON will be at booth #1412 to discuss data governance approaches, rigorous study design techniques and validated frameworks that strengthen the reliability of RWE used in formulary and coverage assessments.

We look forward to connecting in Nashville with teams seeking technical expertise to enhance comparative effectiveness research and support more consistent, evidence based access decisions. https://ow.ly/tZgs50YuBIT

Attending this year? Come along to booth #31 to meet our senior bioanalytical team including Ashley Brant, Amanda Les...
08/04/2026

Attending this year? Come along to booth #31 to meet our senior bioanalytical team including Ashley Brant, Amanda Leskovar, Dave Masters-Moore, Ruqi Wang and Stephanie Fausett. We look forward to discussing how our bioanalytical services can support your drug development from preclinical to phase 4. https://ow.ly/f3Rq50YsMhF

Are you going to the EHRA Congress? If so come along to Lennaert Hoek’s poster presentation on the validity and reliabil...
08/04/2026

Are you going to the EHRA Congress?

If so come along to Lennaert Hoek’s poster presentation on the validity and reliability of a smartwatch single-lead ECG for monitoring QT interval prolongation during an interventional study with moxifloxacin. https://ow.ly/pKCW50YFt4j

Heterogeneity influences the credibility of any meta analysis. Our whitepaper explains how clinical, methodological and ...
08/04/2026

Heterogeneity influences the credibility of any meta analysis.

Our whitepaper explains how clinical, methodological and statistical differences affect evidence synthesis and when fixed effect or random effects models are most appropriate. It provides visual frameworks that help researchers judge whether a network can be pooled responsibly.

Access the whitepaper: https://ow.ly/TTzc50YwbaZ

Address

South County Business Park, Leopardstown
Dublin
18

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+35312912000

Website

Alerts

Be the first to know and let us send you an email when ICON Plc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ICON Plc:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category